Genetics and Parkinson's disease

Journal of Clinical Neuroscience

Volumn 11, Issue 2, 2004, Pages 119-123

  Cordato, Dennis J ^a   Chan, Daniel K Y ^a  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

Author keywords

Gene polymorphisms; parkin; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 2D6; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; HYDROLASE; PARKIN; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 4P; CHROMOSOME 4Q; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENE; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; MENDELIAN INHERITANCE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 1342283131     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2003.10.009     Document Type: Review

References (66)

1. Tanner CM, Ottman R, Goldman SM et al. Parkinson disease in twins: an etiologic study. JAMA 1999; 281: 341-346.
2. de Rijk MC, Tzourio C, Breteler MM et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 10-15.
3. Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999; 45: 577-582.
4. Mouradian MM. Recent advances in the genetics and pathogenesis of Parkinson's disease. Neurology 2002; 58: 179-185.
5. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983; 33: 815-824.
6. Marsden CD. Twins and Parkinson's disease. J Neurolo Neurosurg Psychiatry 1987; 50: 105-106.
7. Chan DKY, Mellick GD, Buchanan DD et al. Lack of association between CYPIAI polymorphism and Parkinson's disease in a Chinese population. J Neural Transm 2002; 109: 35-39.
8. Chi PP, Zhang J, Woo J et al. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease. Mov Disord 1998; 13: 529-532.
9. Nicholl DJ, Bennett P, Hiller L et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology 1999; 53: 1415-1421.
10. Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000; 55: 533-538.
11. Agundez JAG, Jimemez-Jimenez FJ, Luengo A et al. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Neurology 1998; 51: 1587-1592.
12. Harhangi BS, Oostra BA, Heutink P, van Duijn CM, Hofman A, Breteler MMB. N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study. J Neurol Neurosurg Psychiatry 1999; 67: 518-560.
13. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997; 350: 1136-1139.
14. Dupret JM, Longuemaux S, Lucotte G. Acetylator genotype for N-acetyltransferase 2 and Parkinson's disease, Neurology 1999; 46: 433-434.
15. Mellick GD, Buchanan DD, Silburn PA et al. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J Neurol 2000; 247: 52-55.
16. Mellick GD, Buchanan DD, McCann SJ et al. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 1999; 14: 219-224.
17. Chan DKY, Woo J, Ho SC et al. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 1998; 65: 781-784.
18. Leighton PW, Le Couteur DG, Pang CCP et al. The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology 1997; 49: 1577-1579.
19. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides and glutathione transferase polymorphisms. Lancet 1998; 352: 1344-1346.
20. Polymeropoulos MH, Lavedan C, Leroy E et al. Mutations in the α-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
21. Burke RE. α-Synuclein and Parkin: coming together of pieces in puzzle of Parkinson's disease. Lancet 2001; 358: 1567-1568.
22. Polymeropoulos MH. Autosomal dominant Parkinson's disease and α-synuclein. Ann Neurol 1998; 44(Suppl 1): S63-S64.
23. Papapetropoulos S, Paschalis C, Athanassiadou A et al. Clinical phenotype in patients with α-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70: 662-665.
24. Bostantjopoulou S, Katsarou Z, Papadimitrou A, Veletza V, Hatzigeorgiou G, Lees A. Clinical features of patients with the α-synuclein (G209A) mutation. Mov Disord 2001; 16: 1007-1013.
25. Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr α-synuclein mutation. Ann Neurol 2001; 49: 313-319.
26. Chan DKY, Mellick G, Hua C et al. The α-synuclein gene and Parkinson's disease in a Chinese population. Arch Neurol 2000; 57: 501-503.
27. Kruger R, Kuhn W, Muller T et al. AlaP30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998; 18: 106-108.
28. Kitada T, Asakawa S, Hattori N et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
29. Klein C, Pramstaller PP, Kis B et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2000; 48: 65-71.
30. Lucking CB, Durr A, Bonifati V et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. NEJM 2000; 342: 1560-1567.
31. van de Warrenburg BPC, Lammens M, Lucking CB. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 2001; 56: 555-557.
32. Mizuno Y, Hattori N, Mori H, Suzuki T, Tanaka K. Parkin and Parkinson's disease. Curr Opin Neurol 2001; 14: 477-482.
33. Leroy E, Boyer R, Auburger G et al. The ubiquitin pathway in Parkinson's disease. Nature 1998; 395: 451-452.
34. Masliah E, Rockenstein E, Veinbergs I et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000; 287: 1265-1269.
35. Bennett P, Nicholl DJ. Absence of the G209A mutation in the alpha-synuclein gene in British families with Parkinson's disease. Neurology 1998; 50: 1183.
36. Chan P, Tanner CM, Jiang X, Langston JW. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998; 50: 513-514.
37. Munoz E, Oliva R, Obach V et al. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients. Neurosci Lett 1997; 235: 57-60.
38. Wang WW, Khajavi M, Patel BJ et al. The G209A mutation in the α-synuclein gene is not detected in familial cases of Parkinson's disease in non-Greek and/or Italian populations. Arch Neurol 1998; 55: 1521-1523.
39. Hu CJ, Sung SM, Liu H, Chang JG. No mutations of G209A in the alpha-synuclein gene in sporadic Parkinson's disease among Taiwan Chinese. Eur Neurol 1999; 41: 85-87.
40. Gasser T, Muller-Myhsok B, Wszolek ZK et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998; 18: 262-265.
41. Farrer M, Gwinn-Hardy K, Muenter M et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 1999; 8: 81-85.
42. Valente EM, Bentivoglio AR, Dixon PH et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 2001; 68: 895-900.
43. Van Duijn CM, Dekker MC, Bonfati V et al. PARK7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001; 69: 3.
44. Scott WK, Nance MA, Watts RL et al. Complete genomic screen in Parkinson Disease. Evidence for multiple genes. JAMA 2001; 286: 2239-2244.
45. Wang M, Hattori N, Matsumine H et al. Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann Neurol 1999; 45: 655-658.
46. Hu CJ, Sung SM, Liu HC et al. Polymorphisms of the parkin gene in sporadic Parkinson's disease among Chinese in Taiwan. Eur Neurol 2000; 44: 90-93.
47. Klein C, Schumacher K, Jacobs H et al. Association studies of Parkinson's disease and parkin polymorphisms. Ann Neurol 2000; 48: 126-127.
48. Daly AK, Cholerton S, Gregory W, Idle JR. Metabolic polymorphisms. Pharmac Ther 1993; 57: 129-160.
49. Kahn HA. The Dorn Study of smoking among US veterans. In National Cancer Institute, Epidemiologic Approaches to the Study of Cancer and other Diseases. US Government Printing Office, Washington, DC; 1966, Monograph 19: 1-125.
50. Baumann RJ, Jameson HD, McKean HE, Haack DG, Weisburg LM. Cigarette smoking and Parkinson's disease: 1. A comparison of cases with matched neighbors. Neurology 1980; 30: 839-843.
51. Tanner CM, Koller WC, Gilley DC et al. Cigarette smoking, alcohol drinking and Parkinson's disease: a cross-cultural risk assessment. Mov Disord 1990; 5(Suppl 1): 11.
52. Tanner CM, Goldman SM, Aston DA et al. Smoking and Parkinson's disease in twins. Neurology 2002; 58: 581-588.
53. Takakubo F, Yamamoto M, Ogawa N et al. Genetic association between cytochrome P4501A1 gene and susceptibility to Parkinson's disease. J Neur Transm 1996; 103: 843-849.
54. Lucotte G, Turpin JC, Gerard N, Panserat S, Krishnamoorthy R. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson's disease patients and in families. Am J Med Genet 1996; 67: 361-365.
55. Kosel S, Lucking CB, Egensperger R, Mehraein P, Graeber MB. Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 1996; 44: 174-183.
56. Gasser T, Muller-Myhsok B, Supala A et al. The CYP2D6 allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1996; 61: 518-520.
57. Li T, Yang L, Wiese C et al. No association between alleles or genotypes at the dopamine transporter receptor gene and schizophrenia. Psychol Res 1994; 52: 17-23.
58. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Mol Brain Res 1992; 15: 161-166.
59. Le Couteur DG, Leighton PW, McCann SJ, Pond SM. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease, Mov Disord 1997; 12: 760-763.
60. Barker R. Substance P and Parkinson's disease: a causal relationship? J Theor Biol 1986; 120: 353-362.
61. Mellick GD, Buchanan DD, McCann SJ et al. The ACE deletion polymorphism is not associated with Parkinson's disease. Eur Neurol 1999; 41: 103-106.
62. Xu P-Y, Liang R, Jankovic J et al. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 2002; 58: 881-884.
63. Bon MAM, Jansen Steur ENH, de Vos RAI, Vermes I. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci Lett 1999; 266: 149-151.
64. Kruger R, Viera-Saecker AMM, Kuhn W et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined α -synuclein/apolipoprotein E genotype. Ann Neurol 1999; 45: 611-617.
65. Schapira AHV, Cooper JM, Dexter D et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54: 823-827.
66. Mizuno Y, Ohta S, Tanaka M et al. Deficiencies in complex1 subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989; 163:1450-1455.